000 03368nam a22004215i 4500
999 _c10225
_d10225
001 10225
003 DE-He213
005 20210608040357.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180111s2018 gw | s |||| 0|eng d
020 _a9783319699806
024 7 _a10.1007/978-3-319-69980-6
_2doi
040 _bspa
_dES-VaUE
050 4 _aRC254
_b.T75 2018EB
245 1 0 _aTriple-Negative Breast Cancer :
_bA Clinician’s Guide
_cedited by Antoinette R. Tan.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2018.
300 _aXVI, 177 p. 8 illus., 1 illus. in color.
_bonline resource.
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 _aMedicine (Springer-11650)
505 0 _a1. Pathologic evaluation of triple-negative breast cancer -- 2. Triple-negative breast cancer: Clinical features -- 3. The genetics of triple-negative breast cancer -- 4. Imaging features and modalities of triple-negative breast cancer -- 5. Surgical management of triple-negative breast cancer -- 6. Radiation therapy for triple-negative breast cancer -- 7. Tailoring adjuvant therapy for triple-negative breast cancer: Selection of agents -- 8. Neoadjuvant treatment of triple-negative breast cancer -- 9. Systemic treatment of metastatic triple-negative breast cancer Page 3 of 3 -- 10. Molecular profiling and targeted therapy for triple-negative breast cancer -- 11. Special issues in the young woman with triple-negative breast cancer -- 12. Individualizing the approach to the older woman with triple-negative breast Cancer.
520 _aThis guide provides practical information that will assist clinicians involved in the diagnosis, assessment, treatment, and follow-up care of patients with triple-negative breast cancer. After opening chapters on pathologic evaluation, clinical presentation, genetics, and imaging features, the full range of current treatment approaches is thoroughly reviewed from a multidisciplinary perspective. Readers will find up-to-date information and guidance on surgical management, radiation therapy, tailored adjuvant therapy, neoadjuvant treatment, systemic treatment for metastatic disease, and molecular profiling and targeted therapy. The coverage is completed by discussion of special issues in young women and individualization of the management approach in older patients. All healthcare professionals who care for patients with triple-negative breast cancer will find the book to be an invaluable source of expert advice on the issues faced in real-world practice. .
653 0 _aOncology  .
653 0 _aSurgical oncology.
653 0 _aRadiology, Medical.
653 0 _aGynecology.
700 1 _aTan, Antoinette R.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106996
776 0 8 _iPrinted edition:
_z9783319699790
776 0 8 _iPrinted edition:
_z9783319699813
776 0 8 _iPrinted edition:
_z9783319888729
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-69980-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db